Capgemini and Experitest Form Alliance to Offer Mobile Testing Solutions
June 30, 2015 08:30 ET
|
Capgemini Financial Services
PARIS, June 30, 2015 (GLOBE NEWSWIRE) -- Capgemini, one of the world's foremost providers of consulting, technology and outsourcing service, and Experitest, one of the world's leading providers of...
On The Fast Track, ARUP's New and Novel Automation System
June 23, 2015 13:13 ET
|
ARUP Laboratories
SALT LAKE CITY, June 23, 2015 (GLOBE NEWSWIRE) -- "ARUP is one of the most automated laboratories in the United States and the only one in the country to achieve Six-Sigma quality for any pre-analytic...
This is a Test from GlobeNewswire
June 04, 2015 23:56 ET
|
GlobeNewswire, Inc.
LOS ANGELES, June 04, 2015 (GLOBE NEWSWIRE) -- This is a test from GlobeNewswire. Readers are advised to disregard. TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING --...
This is a Test From GlobeNewswire
May 02, 2015 12:32 ET
|
GlobeNewswire, Inc.
LOS ANGELES, May 02, 2015 (GLOBE NEWSWIRE) -- This is a test from GlobeNewswire. Readers are advised to disregard. TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING --...
检验 從 GlobeNewswire
May 02, 2015 12:32 ET
|
GlobeNewswire, Inc.
LOS ANGELES, May 02, 2015 (GLOBE NEWSWIRE) -- 检验 從 GlobeNewswire. 讀者 建議 忽略 測試 --測試-- 測試-- 測試-- 測試-- 測試--測試-- 測試 – -- 結束-- CONTACT: 聯絡: Karen Yu, Director, GlobeNewswire Product...
检验 从 GlobeNewswire
May 02, 2015 12:32 ET
|
GlobeNewswire, Inc.
LOS ANGELES, May 02, 2015 (GLOBE NEWSWIRE) -- 检验 从 GlobeNewswire 读者 建议 忽略. 测试 -- 测试 -- 测试 -- 测试 -- 测试 -- 测试 -- 测试 -- 测试 – -- 结束 -- CONTACT: 联络: Karen Yu, Director, GlobeNewswire Product...
Hemispherx Biopharma to Present Data on the Activity of Ampligen(R) Against the Ebola Virus
March 23, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, March 23, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") will present integrated findings of new studies of Ampligen®...
Hemispherx: U.S. Army Scientists (USAMRIID) Find Ampligen(R) Produces 100% Survival Rate in Ebola Virus Rodent Study
February 02, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Feb. 2, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today the results of a new efficacy study of Ampligen® in a...
Hemispherx Biopharma and United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Collaborate on Alferon(R) and Ampligen(R) Against the Ebola Virus
November 03, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 3, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), has been informed by USAMRIID scientists that they have in-vitro data...
Eriez(r) Releases New Video Spotlighting Orange University(r) Educational Resources, Tools, Testing and Training Opportunities
October 29, 2014 10:48 ET
|
Eriez
Eire, PA, Oct. 29, 2014 (GLOBE NEWSWIRE) -- Eriez®announces the release of a new video that
showcases the many free educational resources, tools, testing and
training opportunities available...